| Company Name: | Idexx Laboratories, Inc. | | Ticker Symbol: | IDXX | | | WWW Address: | www.idexx.com | | CEO: | Jonathan W. Ayers | | No. of Employees: | 4,700 | | Common Issue Type: | CS | | Business Description: | The Company develops, manufactures and distributes products and provides services mainly for the veterinary and the food and water testing markets.
|
| | | Industry Information: | DRUGS - Diagnostic Support [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 50.59 |  0.01 | 50.58 | 50.61 | 50.65 | 51.83 | 50.57 | 123763 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 2,964.6 | 58.6 | 1.12 | 1.87 | 0.00 | 26.8 | 0.0 | 55.69 - 26.74 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 50.58 | $ | | PE Ratio - LTM | 26.8 | |
| Market Capitalisation | 2,963.6 | mil |
| Latest Shares Outstanding | 58.6 | mil |
| Earnings pS (EPS) | 1.87 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 217,879 | $ |
| Effective Tax Rate | 31.7 | % |
| Float | 58.2 | mil |
| Float as % of Shares Outstanding | 99.3 | % |
| Foreign Sales | 403 | mil |
| Domestic Sales | 621 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 27.90 | % |
| Research & Devlopment (R&D) as % of Revenue | 6.60 | % |
| Gross Profit Margin | 56.1 | % |
| EBITDA Margin | 21.7 | % |
| Pre-Tax Profit Margin | 16.5 | % |
| Assets Turnover | 1.3 | % |
| Return on Assets (ROA) | 14.1 | % |
| Return on Equity (ROE) | 23.0 | % |
| Return on Capital Invested (ROCI) | 19.7 | % |
| Current Ratio | 1.9 | |
| Leverage Ratio (Assets/Equity) | 1.6 | |
| Interest Cover | 63.9 | |
| Total Debt/Equity (Gearing Ratio) | 0.30 | |
| LT Debt/Total Capital | 14.0 | % |
| Working Capital pS | 3.19 | $ |
| Cash pS | 1.82 | $ |
| Book-Value pS | 8.53 | $ |
| Tangible Book-Value pS | 4.86 | $ |
| Cash Flow pS | 2.81 | $ |
| Free Cash Flow pS | 1.39 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 5.93 | |
| Price/Tangible Book Ratio | 10.41 | |
| Price/Cash Flow | 18.0 | |
| Price/Free Cash Flow | 36.4 | |
| P/E as % of Industry Group | 119.0 | % |
| P/E as % of Sector Segment | 14.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | -0.3 | 98 | 1,642 | 5,091 |
| 4 Weeks | 53.47 | 50.25 | 51.12 | -1.1 | 93 | 1,835 | 31,188 |
| 13 Weeks | 55.69 | 47.52 | 51.00 | -0.8 | 92 | 2,185 | 133,258 |
| 26 Weeks | 55.69 | 42.34 | 42.00 | 20.4 | 100 | 2,816 | 351,939 |
| 52 Weeks | 55.69 | 26.74 | 30.91 | 63.6 | 133 | 4,508 | 1,122,543 |
| YTD | 55.69 | 27.68 | - | 40.2 | 114 | 4,355 | 988,581 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 51.38 | 51.97 | 51.49 | 48.37 | 44.47 | 1.12 | 1.23 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 14.32 | 94.4 | 11.22 |
| Income | 12.57 | 94.5 | 11.10 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 35.81 | NA | 48.31 |
| R&D | 16.06 | NA | 10.62 |
| Normalized Inc. | 12.32 | NA | 10.53 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -2.5 | 3.2 | 11.0 |
| Earnings % | -1.4 | 22.7 | 23.6 |
| EPS % | 1.4 | 23.8 | 28.1 |
| EPS $ | 0.02 | 0.10 | 0.41 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 7.92 |
| Current Ratio | 1.2 |
| Quick Ratio (Acid Test) | 0.6 |
| Liquidity Ratio (Cash) | 0.27 |
| Receivables Turnover | 9.3 |
| Average Collection Period | 39 |
| Working Capital/Equity | 13.8 |
| Working Capital pS | 1.02 |
| Cash-Flow pS | 2.79 |
| Free Cash-Flow pS | 0.76 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 7.79 |
| Financial Leverage Ratio (Assets/Equity) | 1.7 |
| Debt Ratio | 42.8 |
| Total Debt/Equity (Gearing Ratio) | 0.36 |
| LT Debt/Equity | 0.01 |
| LT Debt/Capital Invested | 7.2 |
| LT Debt/Total Liabilities | 1.6 |
| Interest Cover | 38.1 |
| Interest/Capital Invested | 0.98 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 15.41 |
| Tobin's Q Ratio | 3.87 |
| Current P/E Ratio - LTM | 26.80 |
| Enterprise Value (EV)/EBITDA | 14.52 |
| Enterprise Value (EV)/Free Cash Flow | 87.47 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 10.41 |
| Price/Book Ratio - LTM | 5.93 |
| Price/Cash Flow Ratio | 18.0 |
| Price/Free Cash Flow Ratio - LTM | 36.4 |
| Price/Sales Ratio | 2.95 |
| P/E Ratio (1 month ago) - LTM | 28.8 |
| P/E Ratio (26 weeks ago) - LTM | 22.5 |
| P/E Ratio (52 weeks ago) - LTM | 16.4 |
| 5-Y High P/E Ratio | 44.3 |
| 5-Y Low P/E Ratio | 12.9 |
| 5-Y Average P/E Ratio | 28.7 |
| Current P/E Ratio as % of 5-Y Average P/E | 93 |
| P/E as % of Industry Group | 119.0 |
| P/E as % of Sector Segment | 14.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 26.8 |
| PER SHARE FIGURES |
| LT Debt pS | 0.09 |
| Current Liabilities pS | 4.99 |
| Tangible Book Value pS - LTM | 4.86 |
| Book Value pS - LTM | 8.53 |
| Capital Invested pS | 7.57 |
| Cash pS - LTM | 1.82 |
| Cash Flow pS - LTM | 2.81 |
| Free Cash Flow pS - LTM | 1.39 |
| Earnings pS (EPS) | 1.87 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 4.36 |
| Free Cash Flow Margin 5YEAR AVG | 4.39 |
| Net Profit Margin | 11.3 |
| Net Profit Margin - 5YEAR AVRG. | 11.9 |
| Equity Productivity | 2.34 |
| Return on Equity (ROE) | 26.5 |
| Return on Equity (ROE) - 5YEAR AVRG. | 22.4 |
| Capital Invested Productivity | 2.31 |
| Return on Capital Invested (ROCI) | 26.2 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 22.2 |
| Assets Productivity | 1.40 |
| Return on Assets (ROA) | 15.2 |
| Return on Assets (ROA) - 5YEAR AVRG. | 15.2 |
| Gross Profit Margin | 56.1 |
| Gross Profit Margin - 5YEAR AVRG. | 55.2 |
| EBITDA Margin - LTM | 21.7 |
| EBIT Margin - LTM | 16.8 |
| Pre-Tax Profit Margin | 16.6 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 17.2 |
| Effective Tax Rate | 31.7 |
| Effective Tax Rate - 5YEAR AVRG. | 30.9 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 126 |
| Revenue per Employee | 217,879 |
| Net Income per Employee | 24,717 |
| Average Collection Period | 39 |
| Receivables Turnover | 9.3 |
| Day's Inventory Turnover Ratio | 87 |
| Inventory Turnover | 4.1 |
| Inventory/Sales | 11.3 |
| Accounts Payble/Sales | 2.73 |
| Assets/Revenue | 0.71 |
| Net Working Capital Turnover | 16.90 |
| Fixed Assets Turnover | 2.50 |
| Total Assets Turnover | 1.4 |
| Revenue per $ Cash | 12.98 |
| Revenue per $ Plant | 5.40 |
| Revenue per $ Common Equity | 2.34 |
| Revenue per $ Capital Invested | 2.31 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 28.0 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 27.0 |
| Research & Devlopment (R&D) as % of Revenue | 6.9 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 6.9 |
|
|  
|
| |
 |  |